| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |